fracture healing

Evatanepag (CP-533536 free acid) is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation with EC50 of 0.3 nM.CP-533536 demonstrated the ability to heal fractures when administered locally as a single dose in rat models of fracture healing.

Evatanepag, also known as CP-533536, is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation. CP-533536 demonstrated the ability to heal fractures when administered locally as a single dose in rat models of fracture healing.

Dipsacus saponin R (Compound 1) is an orally active triterpenoid saponin identified in Radix Dipsaci. It aids in bone formation and repair by modulating the activity of osteoblasts or inhibiting the function of osteoclasts. Dipsacus saponin R shows potential for research in bone diseases, such as osteoporosis and fracture healing.

Dipsacus saponin A is an orally active triterpenoid saponin found in the roots of Dipsacus asper. It promotes bone repair by regulating osteoblast activity and inhibiting osteoclast function. Dipsacus saponin A shows potential for research in conditions such as fracture healing and osteoporosis.

Fmoc-Cys-Asp10 (TFA) is a non-releasable oligopeptide linker involved in synthesizing releasable oligopeptide linkers. These releasable linkers are used to deliver drugs to fracture-targeting oligopeptides, thereby reducing the healing time of fractured femurs.